Background: Venous thromboembolism (VTE) is a common source of perioperative
morbidity and mortality. Objective: These evidence-based guidelines from the American …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Seventh American College of Chest Physicians Conference on Antithrombotic and …

Background VTE is a common cause of preventable death in surgical patients. Methods We
developed recommendations for thromboprophylaxis in nonorthopedic surgical patients by …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Venous thromboembolism (VTE) represents one of the most important causes of morbidity
and mortality in cancer patients. According to population-based case–control studies, the 2 …

After almost two decades of intensive research, low-molecular-weight heparins have
established their niche as an important class of antithrombotic compounds. The …

• Design: either prospective cohort studies or control groups of randomized trials•
Interventions: no prophylaxis used

Background Meta-analyses are now widely used to provide evidence to support clinical
strategies. However, large randomized, controlled trials are considered the gold standard in …

Background: Low molecular weight heparins (LMWHs) have become routine
thromboprophylaxis in general surgery. However, their actual clinical effect, its magnitude …

The most common indications for warfarin therapy are atrial fibrillation, the presence of a
mechanical heart valve, and venous thromboembolism. 1, 2 Treatment with warfarin …